AMB-FUBINACA (ADB-FUBINACA)
A third-wave synthetic cannabinoid of the fluorobenzyl indazole carboxamide scaffold identified in the 2016 New York mass-poisoning event; associated with intense, prolonged CB1 receptor activation and serious adverse effects.